2 Biotech ETFs To Monitor For Potential Breakouts – And Possible Trading Plays For Both
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
“This is a market that favors stock picking over market timing and macro analysis,” advises the author of today’s article, who argues that “The business…
While the authors of today’s article are stock pickers, they argue that there are some situations where exchange-traded funds are the better option – and…
Sustainable investing has gone from niche to mainstream – and a number of the sustainable companies highlighted in today’s article put an emphasis on sustainability…
For those investing for the long-term, the best thing to do in response to current market turmoil, driven by fears surrounding the novel coronavirus, may…
If income is what you’re after in this low-interest-rate environment, and you prefer to avoid the risk associated with stocks, one alternative source of income…
While earnings are declining, the author of today’s article points out an important fact about the decline: it’s being largely driven by companies that rely…
They offer large-cap-like quality combined with small-cap-like growth – and yet these strong performers are underrepresented in investors’ portfolios. We’re talking about mid-cap stocks, which…
The ETF highlighted in today’s article may be a particularly appealing pick right now. Why? In addition to its very low credit risk and predictable…
With hedge funds, bonds and gold all having potential drawbacks as long-term investments, the author of today’s article highlights “a groundbreaking investment idea” for those…